Stay updated on Viatris Press Releases

Sign up to get notified when there's something new on the Viatris Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Viatris Press Releases page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Viatris has presented a late-breaking abstract on Cenerimod at a major rheumatology congress, while a previous announcement regarding the appointment of a new board member has been removed.
    Difference
    22%
    Check dated 2024-08-28T03:18:45.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Viatris has reported its second quarter financial results for 2024, while a previous announcement regarding participation in the Jeffries Global Healthcare Conference has been removed.
    Difference
    15%
    Check dated 2024-08-14T00:09:53.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Viatris has announced its second quarter 2024 dividend, while the 2023 Sustainability Report has been removed from the website.
    Difference
    14%
    Check dated 2024-08-06T22:46:00.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The value on the webpage has changed from reporting strong first quarter financial results and reaffirming financial guidance ranges to announcing the completion of all previously announced divestitures with the closing of its Over-the-Counter Business Divestiture.
    Difference
    23%
    Check dated 2024-07-03T15:49:49.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The U.S. Department of Justice has informed Viatris that it no longer considers Mylan a subject of the generic drug industry antitrust investigation, marking a significant update from the previous status.
    Difference
    25%
    Check dated 2024-07-02T15:34:21.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The recent change on the webpage reflects Viatris' statement regarding the European Commission's approval for the proposed divestiture of its Over-the-Counter business to Cooper Consumer Health, replacing the previous information about the expansion of its wellbeing program with the launch of Unmind.
    Difference
    28%
    Check dated 2024-06-27T11:54:26.000Z thumbnail image

Stay in the know with updates to Viatris Press Releases

Enter your email address, and we'll notify you when there's something new on the Viatris Press Releases page.